Vaccines and Related Biological Products Advisory Committee
February 18 - 19, 2004 Meeting
Date and Time:
The meeting will be held on February 18, 2004, from 8:30 am to 4:30 pm; and February 19, 2004, from 8:30 am to 12:30 pm.
Location:
Sheraton Four-Points Hotel, 8400 Wisconsin Avenue, Bethesda, MD 301-654-1000.
Contact Persons:
William Freas, Ph.D. or Denise Royster, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512391. Please call the Information Line for up-to-date information on this meeting.
Agenda:
The Committee will review and discuss the selection of strains to be included in the influenza virus vaccine for the 2004-2005 season. The Committee and CBER will begin a discussion of the potential suitability for use in vaccine manufacture of influenza isolates that have been passaged through mammalian cells (e.g., MDCK cells or Vero cells).
Oral Presentations:
Between approximately 1:00 and 1:30 p.m. on February 18, 2004; and 8:45 and 9:15 a.m. on February 19, 2004, oral presentations from the public will be scheduled. Those desiring to make formal oral presentations should notify the contact person before February 13, 2004.
|
